Yet, the expense and often difficult logistics of Phase II and III drug trials still prevent full implementation of these advances. The entire world yearns for vaccine development, but optimistically that is still many years in the future. In the meantime, inexpensive drugs are still desperately needed. In 5-10 years, we hope that additional emphasis will have been placed by the entire global community on the rapid development and deployment of inexpensive anti malarial drugs. More funding and effort directed towards a multi-tiered, balanced approach to malaria treatment and prevention is very much needed. For over 60 years, inexpensive anti malarial drugs have saved the lives of many millions of malaria victims. In theory, there is no scientific roadblock that cannot be overcome such that this continues to be the case well into the future.